Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young Children.

American journal of hematology·2026
Same author

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

JCO precision oncology·2026
Same author

Precision management of cenobamate in drug-resistant epilepsy: integrating pharmacogenetics, therapeutic drug monitoring, and real-world clinical strategies.

Frontiers in pharmacology·2026
Same author

Corrigendum to "Glutaminase deficiency provides insight to the role of glutamine accumulation and neurotoxicity" [Mol. Genet. Metab. 148(2) (2026) 109906].

Molecular genetics and metabolism·2026
Same author

The impact of cardiovascular risk factors in non-classical Fabry disease.

Orphanet journal of rare diseases·2026
Same author

High-dose continuous infusion of piperacillin/tazobactam via elastomeric pump in a pediatric patient with Kartagener syndrome: pharmacokinetic target attainment and clinical outcome.

Journal of chemotherapy (Florence, Italy)·2026

Related Experiment Video

Updated: Aug 4, 2025

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

14.7K

Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.

Yvette A H Matser1,2, Iedan R N Verly1,2, Maria van der Ham3

  • 1Princess Máxima Centre for Paediatric Oncology, Utrecht, The Netherlands.

Pediatric Blood & Cancer
|April 3, 2023
PubMed
Summary

Spot urine samples provide reliable analysis for neuroblastoma diagnostics, matching the accuracy of 24-hour collections. A comprehensive panel of eight catecholamine metabolites offers superior diagnostic performance compared to traditional markers like HVA and VMA.

Keywords:
catecholamine metabolitesdiagnostic sensitivitymetanephrinesneuroblastomatandem mass spectrometryurine collection

More Related Videos

Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications
08:41

Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications

Published on: July 14, 2017

9.4K
Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging
04:33

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Published on: December 8, 2023

947

Related Experiment Videos

Last Updated: Aug 4, 2025

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

14.7K
Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications
08:41

Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications

Published on: July 14, 2017

9.4K
Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging
04:33

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Published on: December 8, 2023

947

Area of Science:

  • Biochemistry
  • Pediatric Oncology
  • Clinical Diagnostics

Background:

  • Urinary catecholamine metabolite analysis is crucial for neuroblastoma diagnosis.
  • Current diagnostic practices lack consensus on optimal urine sampling methods and metabolite panels.
  • Variability in methods impacts diagnostic accuracy and reliability.

Purpose of the Study:

  • To evaluate the reliability of spot urine samples for analyzing a panel of catecholamine metabolites in neuroblastoma diagnosis.
  • To compare the diagnostic performance of spot urine versus 24-hour urine collections.
  • To assess the diagnostic accuracy of an expanded panel of eight catecholamine metabolites.

Main Methods:

  • Collected spot urine and 24-hour urine samples from neuroblastoma patients and controls.
  • Measured eight catecholamine metabolites (HVA, VMA, dopamine, 3-methoxytyramine, norepinephrine, normetanephrine, epinephrine, metanephrine) using HPLC-FD and UPLC-MS/MS.
  • Analyzed diagnostic sensitivity and receiver-operating-characteristic curves (AUC) for individual metabolites and panels.

Main Results:

  • Spot urine and 24-hour urine samples showed similar excretion levels and diagnostic sensitivities for all measured catecholamine metabolites.
  • The panel of eight catecholamine metabolites demonstrated significantly higher diagnostic accuracy (AUC = 0.952) than the traditional panel of HVA and VMA (AUC = 0.920).
  • No significant differences in metabolite levels were observed between HPLC-FD and UPLC-MS/MS analysis methods.

Conclusions:

  • Spot urine samples are a reliable and effective alternative to 24-hour urine collections for neuroblastoma diagnosis.
  • The Catecholamine Working Group recommends adopting spot urine analysis as the standard of care.
  • An eight-metabolite panel offers superior diagnostic accuracy for neuroblastoma compared to using only HVA and VMA.